FACC FESC - Cytosorbents Crp Chief Officer
| CTSO Stock | USD 1.13 0.03 2.73% |
Insider
FACC FESC is Chief Officer of Cytosorbents Crp
| Age | 53 |
| Address | 305 College Road East, Princeton, NJ, United States, 08540 |
| Phone | 732 329 8885 |
| Web | https://www.cytosorbents.com |
Cytosorbents Crp Management Efficiency
The company has return on total asset (ROA) of (0.2793) % which means that it has lost $0.2793 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.185) %, meaning that it created substantial loss on money invested by shareholders. Cytosorbents Crp's management efficiency ratios could be used to measure how well Cytosorbents Crp manages its routine affairs as well as how well it operates its assets and liabilities. As of the 19th of March 2025, Return On Tangible Assets is likely to drop to -0.55. In addition to that, Return On Capital Employed is likely to grow to -0.88. At this time, Cytosorbents Crp's Total Assets are very stable compared to the past year. As of the 19th of March 2025, Non Current Assets Total is likely to grow to about 33.3 M, while Total Current Assets are likely to drop about 17.6 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| BA Chemistry | Orthofix Medical | 63 | |
| John Davis | Artivion | 60 | |
| Mark Saxton | Neuropace | 59 | |
| Amy Horton | Artivion | 50 | |
| Antony Koblish | Tela Bio | 59 | |
| Scott Capps | Artivion | 53 | |
| Thomas Ackerman | Artivion | 66 | |
| Rochelle Maney | Artivion | 45 | |
| Kristin Caltrider | Inogen Inc | 56 | |
| Nabil Shabshab | Inogen Inc | 59 | |
| Erik Mickelson | Paragon 28 | 42 | |
| Christopher Holland | Electromed | 55 | |
| Jared Oasheim | CVRx Inc | 41 | |
| Michael Favet | Neuropace | 54 | |
| Martha Morrell | Neuropace | 67 | |
| Paul Talmo | Tela Bio | 53 | |
| Andre Marquette | Neuropace | N/A | |
| Peter Murphy | Tela Bio | 52 | |
| Marshall Stanton | Artivion | 64 | |
| F Barthold | Artivion | 56 | |
| B Johnson | Paragon 28 | 68 | |
Management Performance
| Return On Equity | -1.18 | ||||
| Return On Asset | -0.28 |
Cytosorbents Crp Leadership Team
Elected by the shareholders, the Cytosorbents Crp's board of directors comprises two types of representatives: Cytosorbents Crp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cytosorbents. The board's role is to monitor Cytosorbents Crp's management team and ensure that shareholders' interests are well served. Cytosorbents Crp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cytosorbents Crp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA, CFO Sec | ||
| Robert MD, CoChairman Consultant | ||
| MS MS, Pres COO | ||
| Christian MD, Executive Marketing | ||
| MS MBA, Senior Development | ||
| Terri MBA, Vice Communications | ||
| Vincent MS, President COO | ||
| FACC FESC, Chief Officer | ||
| Irina Kulinets, Senior Affairs | ||
| Peter CPA, Chief Officer | ||
| Jodi Hoover, Executive |
Cytosorbents Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cytosorbents Crp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.18 | ||||
| Return On Asset | -0.28 | ||||
| Profit Margin | (0.49) % | ||||
| Operating Margin | (0.46) % | ||||
| Current Valuation | 91.57 M | ||||
| Shares Outstanding | 62.35 M | ||||
| Shares Owned By Insiders | 9.72 % | ||||
| Shares Owned By Institutions | 29.71 % | ||||
| Number Of Shares Shorted | 1.95 M | ||||
| Price To Earning | (16.30) X |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytosorbents Crp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytosorbents Crp. If investors know Cytosorbents will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytosorbents Crp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.36) | Revenue Per Share | Quarterly Revenue Growth 0.066 | Return On Assets | Return On Equity |
The market value of Cytosorbents Crp is measured differently than its book value, which is the value of Cytosorbents that is recorded on the company's balance sheet. Investors also form their own opinion of Cytosorbents Crp's value that differs from its market value or its book value, called intrinsic value, which is Cytosorbents Crp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytosorbents Crp's market value can be influenced by many factors that don't directly affect Cytosorbents Crp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytosorbents Crp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytosorbents Crp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytosorbents Crp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.